Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eating | 3 | 2022 | 380 | 1.310 |
Why?
|
| Acid-Base Equilibrium | 1 | 2022 | 28 | 0.780 |
Why?
|
| Acute Kidney Injury | 2 | 2024 | 807 | 0.580 |
Why?
|
| Liver Transplantation | 1 | 2022 | 870 | 0.450 |
Why?
|
| Hypertension | 2 | 2025 | 1291 | 0.450 |
Why?
|
| Kidney Transplantation | 3 | 2024 | 695 | 0.390 |
Why?
|
| Osmolar Concentration | 2 | 2022 | 174 | 0.380 |
Why?
|
| Transition to Adult Care | 2 | 2023 | 81 | 0.340 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2025 | 608 | 0.300 |
Why?
|
| Urologic Surgical Procedures | 2 | 2024 | 115 | 0.260 |
Why?
|
| Nephrotic Syndrome | 1 | 2024 | 37 | 0.220 |
Why?
|
| Nephritis, Interstitial | 1 | 2024 | 14 | 0.220 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2024 | 47 | 0.220 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2023 | 11 | 0.210 |
Why?
|
| Immunosuppressive Agents | 3 | 2024 | 886 | 0.200 |
Why?
|
| Propensity Score | 1 | 2024 | 287 | 0.200 |
Why?
|
| Adolescent | 10 | 2025 | 21402 | 0.200 |
Why?
|
| Drug Prescriptions | 1 | 2024 | 250 | 0.200 |
Why?
|
| Hemodiafiltration | 1 | 2022 | 9 | 0.190 |
Why?
|
| Child | 10 | 2025 | 21896 | 0.190 |
Why?
|
| Pain, Postoperative | 1 | 2024 | 271 | 0.190 |
Why?
|
| Renal Replacement Therapy | 1 | 2022 | 91 | 0.190 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2024 | 346 | 0.180 |
Why?
|
| Antihypertensive Agents | 1 | 2025 | 493 | 0.180 |
Why?
|
| Recurrence | 1 | 2024 | 1058 | 0.180 |
Why?
|
| Hypotension | 1 | 2022 | 123 | 0.170 |
Why?
|
| Postoperative Complications | 2 | 2024 | 2627 | 0.170 |
Why?
|
| Tacrolimus | 1 | 2021 | 199 | 0.160 |
Why?
|
| Blood Pressure Determination | 1 | 2019 | 156 | 0.140 |
Why?
|
| Organ Transplantation | 1 | 2021 | 248 | 0.140 |
Why?
|
| Drug Overdose | 1 | 2022 | 344 | 0.140 |
Why?
|
| Renal Dialysis | 1 | 2021 | 434 | 0.140 |
Why?
|
| Retrospective Studies | 6 | 2024 | 15514 | 0.130 |
Why?
|
| Blood Pressure | 2 | 2025 | 1774 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 993 | 0.130 |
Why?
|
| Humans | 14 | 2025 | 136899 | 0.130 |
Why?
|
| Critical Illness | 1 | 2022 | 805 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2024 | 1310 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 560 | 0.120 |
Why?
|
| Comorbidity | 1 | 2019 | 1611 | 0.110 |
Why?
|
| Prevalence | 1 | 2019 | 2709 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1575 | 0.090 |
Why?
|
| Mass Screening | 1 | 2019 | 1262 | 0.090 |
Why?
|
| Risk Factors | 2 | 2024 | 10313 | 0.080 |
Why?
|
| Infant | 1 | 2022 | 9408 | 0.070 |
Why?
|
| United States | 2 | 2024 | 14595 | 0.060 |
Why?
|
| Obesity | 1 | 2019 | 2966 | 0.060 |
Why?
|
| Calcineurin Inhibitors | 1 | 2024 | 72 | 0.050 |
Why?
|
| Remission Induction | 1 | 2024 | 286 | 0.050 |
Why?
|
| Viremia | 1 | 2024 | 135 | 0.050 |
Why?
|
| Proteinuria | 1 | 2023 | 98 | 0.050 |
Why?
|
| Male | 6 | 2025 | 67308 | 0.050 |
Why?
|
| Kidney Glomerulus | 1 | 2023 | 114 | 0.050 |
Why?
|
| Toxicokinetics | 1 | 2022 | 9 | 0.050 |
Why?
|
| Valproic Acid | 1 | 2022 | 47 | 0.050 |
Why?
|
| Female | 6 | 2025 | 72703 | 0.050 |
Why?
|
| Graft Survival | 1 | 2024 | 539 | 0.050 |
Why?
|
| Young Adult | 3 | 2023 | 13157 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2024 | 11013 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2021 | 302 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2021 | 811 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 2844 | 0.030 |
Why?
|
| Incidence | 1 | 2024 | 2783 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2021 | 514 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 1460 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2024 | 3432 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 5711 | 0.030 |
Why?
|
| Caregivers | 1 | 2021 | 865 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 5398 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 10768 | 0.020 |
Why?
|
| Quality of Life | 1 | 2021 | 2847 | 0.020 |
Why?
|